Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
4.550
+0.110 (2.48%)
At close: Oct 2, 2026, 4:00 PM EDT
4.580
+0.030 (0.66%)
After-hours: Oct 2, 2026, 7:20 PM EDT
Aquestive Therapeutics Market Cap
Aquestive Therapeutics has a market cap or net worth of $571.08 million as of October 2, 2026. Its market cap has decreased by -2.61% in one year.
Market Cap
571.08M
Enterprise Value
531.62M
1-Year Change
-2.61%
Ranking
Category
Stock Price
$4.55
ChartMarket Cap Chart
Since July 25, 2018, Aquestive Therapeutics's market cap has increased from $385.20M to $571.08M, an increase of 48.25%. That is a compound annual growth rate of 4.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 571.08M | -27.54% |
| Dec 31, 2025 | 788.10M | 142.79% |
| Dec 31, 2024 | 324.60M | 140.62% |
| Dec 29, 2023 | 134.90M | 176.43% |
| Dec 30, 2022 | 48.80M | -68.76% |
| Dec 31, 2021 | 156.20M | -13.17% |
| Dec 31, 2020 | 179.90M | 23.39% |
| Dec 31, 2019 | 145.80M | -7.19% |
| Dec 31, 2018 | 157.10M | -59.22% |
| Jul 25, 2018 | 385.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pacira BioSciences | 1.02B |
| Collegium Pharmaceutical | 714.60M |
| Ironwood Pharmaceuticals | 676.66M |
| Evotec SE | 594.18M |
| Glass House Brands | 582.42M |
| Tilray Brands | 534.27M |
| Evolus | 527.74M |
| Kamada | 498.65M |